TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 61 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,118 | -84.8% | 1,276 | -84.7% | 0.00% | -100.0% |
| Q2 2023 | $316,449 | +49.1% | 8,343 | -4.4% | 0.00% | – |
| Q1 2023 | $212,192 | -16.5% | 8,725 | -0.3% | 0.00% | – |
| Q4 2022 | $254,187 | -13.8% | 8,753 | -10.7% | 0.00% | -100.0% |
| Q3 2022 | $295,000 | -19.2% | 9,805 | -2.8% | 0.00% | 0.0% |
| Q2 2022 | $365,000 | -19.4% | 10,091 | -3.8% | 0.00% | 0.0% |
| Q1 2022 | $453,000 | -9.8% | 10,487 | +4.4% | 0.00% | 0.0% |
| Q4 2021 | $502,000 | -26.3% | 10,043 | -6.1% | 0.00% | 0.0% |
| Q3 2021 | $681,000 | -15.0% | 10,696 | -4.0% | 0.00% | -50.0% |
| Q2 2021 | $801,000 | -5.1% | 11,144 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $844,000 | +0.6% | 11,447 | +0.1% | 0.00% | 0.0% |
| Q4 2020 | $839,000 | +24.7% | 11,438 | -6.6% | 0.00% | 0.0% |
| Q3 2020 | $673,000 | -17.7% | 12,252 | -0.4% | 0.00% | 0.0% |
| Q2 2020 | $818,000 | +0.1% | 12,301 | -7.8% | 0.00% | -33.3% |
| Q1 2020 | $817,000 | -35.6% | 13,336 | -7.5% | 0.00% | 0.0% |
| Q4 2019 | $1,268,000 | +10.7% | 14,421 | -5.0% | 0.00% | 0.0% |
| Q3 2019 | $1,145,000 | -0.5% | 15,177 | +12.5% | 0.00% | 0.0% |
| Q2 2019 | $1,151,000 | +17.6% | 13,486 | +48.8% | 0.00% | 0.0% |
| Q1 2019 | $979,000 | +13885.7% | 9,065 | +11091.4% | 0.00% | – |
| Q4 2018 | $7,000 | +40.0% | 81 | +68.8% | 0.00% | – |
| Q3 2018 | $5,000 | -61.5% | 48 | -57.9% | 0.00% | – |
| Q2 2018 | $13,000 | -18.8% | 114 | -30.5% | 0.00% | – |
| Q1 2018 | $16,000 | -84.3% | 164 | -83.2% | 0.00% | – |
| Q4 2017 | $102,000 | -37.0% | 979 | -31.8% | 0.00% | -100.0% |
| Q3 2017 | $162,000 | -51.5% | 1,436 | -51.9% | 0.00% | 0.0% |
| Q2 2017 | $334,000 | +43.3% | 2,983 | +49.4% | 0.00% | 0.0% |
| Q1 2017 | $233,000 | +89.4% | 1,997 | +71.1% | 0.00% | – |
| Q4 2016 | $123,000 | -79.7% | 1,167 | -78.6% | 0.00% | -100.0% |
| Q3 2016 | $605,000 | -26.6% | 5,466 | -3.4% | 0.00% | -33.3% |
| Q2 2016 | $824,000 | +3.0% | 5,659 | +1.3% | 0.00% | 0.0% |
| Q1 2016 | $800,000 | -5.9% | 5,588 | +1.5% | 0.00% | 0.0% |
| Q4 2015 | $850,000 | -28.9% | 5,503 | -34.2% | 0.00% | -40.0% |
| Q3 2015 | $1,195,000 | +8.9% | 8,357 | +9.5% | 0.01% | +25.0% |
| Q2 2015 | $1,097,000 | +2.0% | 7,632 | +0.2% | 0.00% | 0.0% |
| Q1 2015 | $1,075,000 | – | 7,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |